B-CONVINCED: Beta-blocker CONtinuation Vs. INterruption in patients with Congestive heart failure hospitalizED for a

decompensation episode

by Guillaume Jondeau, Yannick Neuder, Jean-Christophe Eicher, Patrick Jourdain, Elodie Fauveau, Michel Galinier, Arnaud Jegou, Fabrice Bauer, Jean Noel Trochu,

Anissa Bouzamondo, Marie-Laure Tanguy, and Philippe Lechat

EHJVolume ():ehp323August 30, 2009

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2009. For permissions please email: journals.permissions@oxfordjournals.org

Evolution of heart rate (top) and systolic and diastolic blood pressure (bottom) in the two groups.

Guillaume Jondeau et al. Eur Heart J 2009;eurheartj.ehp323

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2009. For permissions please email: journals.permissions@oxfordjournals.org

Percentage of patients improved for both general well-being and dyspnoea according to the fact that they keep (green) or stop (red) beta-blocker therapy, evaluated by a blinded investigator

(investigator) or the patient (patient), at Day 3 and at Day 8.

Guillaume Jondeau et al. Eur Heart J 2009;eurheartj.ehp323

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2009. For permissions please email: journals.permissions@oxfordjournals.org